SprintRay Inc.
- Industry
- Medical Equipment Manufacturing
- Founded Year
- 2014
- Headquarters
- Los Angeles, California, USA
- Employee Count
- 200
Key People
- Amir Mansouri - Co-Founder and CEO
- Jing Zhang - Co-Founder and CTO
- Jessie Zhang - Chief Financial Officer
- Meena Barsoum - Global Head of Clinical Strategy
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a strong background in MedTech and digital dentistry.
The presence of multiple successful MedTech entrepreneurs in the leadership team enhances the company's capability to navigate the complexities of the medical device industry and drive product development effectively.
- Clinical Need
-
Aspect: Very Strong
Summary: SprintRay addresses a significant need for efficient, in-office dental manufacturing solutions.
By providing end-to-end 3D printing solutions tailored for dental professionals, SprintRay enables practices to produce dental prosthetics and appliances in-house, reducing turnaround times and costs associated with outsourcing.
- Competition
-
Aspect: Somewhat crowded
Summary: The dental 3D printing market has multiple players, but SprintRay maintains a competitive edge.
The market for dental 3D printing includes several competitors; however, SprintRay's emphasis on providing comprehensive, easy-to-use systems tailored for dental professionals helps it stand out in the industry.
- Technical Challenge
-
Aspect: Predictable
Summary: The technical challenges associated with dental 3D printing are well-understood and manageable.
With a strong R&D team and a focus on dental applications, SprintRay is well-equipped to handle the technical aspects of 3D printing, ensuring reliable and high-quality outputs for dental practices.
- Patent
-
Aspect: Very Strong
Summary: SprintRay holds a robust portfolio of patents in 3D printing technologies.
SprintRay's patents cover various aspects of 3D printing, including hardware designs and post-processing methods, reinforcing its position as a leader in dental 3D printing technology.
- Financing
-
Aspect: Well-funded
Summary: SprintRay has secured significant funding from reputable investors.
With a Series D funding round led by SoftBank Vision Fund and participation from other notable investors, SprintRay is well-capitalized to expand its market presence and enhance its product offerings.
- Regulatory
-
Aspect: 510k/PMA
Summary: SprintRay's products have obtained necessary regulatory approvals for market entry.
By securing FDA 510(k) clearances and other relevant certifications, SprintRay demonstrates its commitment to meeting regulatory requirements, facilitating trust and adoption among dental professionals.
Opportunity Rollup
- Odds of Success
- 3.8
- Peak Market Share
- 4.85
- Segment CAGR
- 5.0%
- Market Segment
- Dental Devices
- Market Sub Segment
- Dental 3D Printing
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.73 |
| 3 | 1.70 |
| 4 | 3.40 |
| 5 | 4.85 |
Key Takeaway
SprintRay's strong leadership, robust patent portfolio, and focus on digital dentistry position it well in the growing dental 3D printing market.